Endometriosis – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Endometriosis – Drugs In Development, 2024 report and make more profitable business decisions.
Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (endometrium) grows outside uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility, and abnormal bleeding. Risk factors include age, uterine abnormalities, history of pelvic infection, and family history. Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs), birth control pills, and progestins.
The Endometriosis drugs in development market research report provide comprehensive information on the therapeutics under development for Endometriosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Endometriosis and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Endometriosis | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 66 molecules, with 61 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Endometriosis therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Endometriosis pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Endometriosis treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Abalone Bio IncAdynxx Inc
Aptorum Group Ltd
Bayer AG
BCI Pharma SA
Bio Genuine
Chugai Pharmaceutical Co Ltd
Daewon Pharmaceutical Co Ltd
Daewoong Pharmaceutical Co Ltd
Egret Therapeutics Inc
Eikonoklastes Therapeutics Inc
ElexoPharm GmbH
Endomet Biosciences Inc
Enteris BioPharma Inc
EpicentRx Inc
Eurofarma Laboratorios SA
Evestra Inc
Evotec SE
Fimmcyte AG
Flightpath BioSciences Inc
Foresee Pharmaceuticals Co Ltd
Freya Biosciences ApS
Fuji Pharma Co Ltd
Gesynta Pharma AB
Hangzhou Metai Pharmaceutical Technology Co Ltd
Hope Medicine Inc
Immunitor Inc
Insud Pharma
Ironwood Pharmaceuticals Inc
Jiangsu Hengrui Medicine Co Ltd
Kissei Pharmaceutical Co Ltd
Livzon Pharmaceutical Group Co Ltd
Massachusetts Institute of Technology
Miami VA Healthcare System
Mitsubishi Tanabe Pharma Corp
Navad Life Sciences Pte Ltd
Nippon Shinyaku Co Ltd
Organon & Co
Predictive Therapeutics LLC
PregLem SA
Sino Biopharmaceutical Ltd
SLBST Pharma Inc
Sur180 Therapeutics LLC
SYNG Pharmaceuticals Inc
Synokem Pharmaceuticals Ltd
Tel Aviv University
Temple Therapeutics BV
Texas A&M University
TiumBio Co Ltd
ValiRx Plc
VaRi Bioscience GmbH
Viramal Ltd
Xbrane Biopharma AB
Yantai Chuanghe Biotechnology Co Ltd
Zydus Lifesciences Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Endometriosis reports